Sprout Pharmaceuticals Inc. has gained Food and Drug Administration clearance to market Addyi, which the company calls the first FDA-approved medication for hypoactive sexual desire disorder (HSDD) in women. Sprout said late Tuesday that Addyi (flibanserin, 100 mg) is slated to be released by Oct.
Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for cetirizine hydrochloride tablets, 5 mg and 10 mg, an over-the-counter allergy medication.
Lannett Co. and Amneal Pharmaceuticals LLC have launched the first generic versions of Abilify oral solution (aripiprazole 1 mg/ml), Otsuka Pharmaceutical’s antidepressant drug.
Eli Lilly & Co. has rolled out the Humalog 200 units/ml KwikPen to U.S. pharmacies, calling the medication the nation’s first and only concentrated mealtime insulin analog.
Retail clinic patients find the telehealth experience very satisfying, according to a CVS Health Research Institute study of a pilot program at MinuteClinic.
AmerisourceBergen Corp. and its Good Neighbor Pharmacy network will employ technology from PrescribeWellness to deliver and maintain the company’s new Patient Engagement Center.
CVS Health has finalized its $12.9 billion acquisition of Omnicare, a leading provider of pharmacy services to long-term care facilities.
Walgreens and Rite Aid have commenced their annual flu shot campaigns, providing consumers with a range of vaccine options and making it easy for people to get immunized against influenza.
CVS Health is launching a new pharmacy service called ScriptSync, which promises to make it easier and more convenient for patients to take multiple medications as prescribed.
Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg.
The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute.
FLAVORx aims to help improve adherence to pediatric medications with the launch of its first mobile application for iPhone.
AmerisourceBergen Corp. has launched the AmerisourceBergen Foundation, a nonprofit charitable organization that provides grants to health- and pharmaceutical-related causes and educational opportunities.
Elizabeth Keyes, chief operating officer of the American Pharmacists Association (APhA), has been named as interim executive director of the APhA Foundation with the departure of Mindy Smith.
Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety. Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc. Part of a group of
Aprecia Pharmaceuticals Co. has received Food and Drug Administration approval for Spritam levetiracetam for oral use, an epilepsy treatment made using three-dimensional printing (3DP) technology.
